IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label international trade commission. Show all posts
Showing posts with label international trade commission. Show all posts
Wednesday, 31 January 2024

U.S. International Trade Commission Covid-19 Diagnostics and Treatment Development and Access Report

›
The U.S. International Trade Commission released a corrected version of its COVID-19 Diagnostics and Therapeutics: Supply, Demand and TRIPS ...
Thursday, 2 January 2020

U.S. Agencies Release Policy Statement Concerning Remedies and SEPs

›
The United States Patent and Trademark Office, the U.S. National Institute of Standards and Technology, and the U.S. Department of Justice, ...
›
Home
View web version
Powered by Blogger.